Fierce Pharma

OCTOBER 28, 2024

Novartis and Apellis Pharmaceuticals have rolled out detailed data on iptacopan and pegcetacoplan, respectively, as they race for the prize in a type of rare kidney disease. | Novartis and Apellis dropped new data on their respective meds, iptacopan and pegcetacoplan, in the rare kidney disease C3 glomerulopathy. While Apellis' drug seems to have an efficacy edge based on a cross-trial comparison, Novartis may have gotten the jump by filing for approvals ahead of its competitor.

Pharmaceutical 328

Pharmaceutical 328

PharmaVoice

OCTOBER 28, 2024

As antimicrobial resistance rises, researchers are running out of time to fight each new wave of superbugs. And the funding isn’t enough.

142

142

Fierce Pharma

OCTOBER 28, 2024

Earlier this year, EyePoint Pharmaceuticals’ drug-device combo Duravyu missed the mark in a non-proliferative diabetic retinopathy (NPDR) study, raising doubts about the product’s potential in seve | EyePoint released new diabetic macular edema data Monday that a Mizuho Securities analyst described as "very promising." The trial win provides a needed turnaround for the company's lead candidate Duravyu, which failed a study in non-proliferative diabetic retinopathy earlier this yea

Leads 294

Leads Pharmaceutical 294

MedCity News

OCTOBER 28, 2024

The healthcare industry’s inability to coordinate care effectively and at scale is the single biggest issue in the sector, said Tampa General Hospital CEO John Couris. The post This Problem Keeps Hospital Execs Up at Night, Tampa General Hospital CEO Says appeared first on MedCity News.

Healthcare 135

Healthcare Healthcare 135

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

OCTOBER 28, 2024

While Astellas’ Izervay and Apellis’ Syfovre battle for market share in geographic atrophy (GA) in the United States, both companies are struggling to reach patients in the indication in Europe.&nb | While Astellas’ Izervay and Apellis’ Syfovre battle for market share in geographic atrophy (GA) in the United States, both companies are struggling to reach patients in the indication in Europe.

Medicine 315

Medicine Marketing Patients 315

pharmaphorum

OCTOBER 28, 2024

Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class therapies for the disorder.Data reported at the Kidney Week 2024 congress in San Diego showed that felzartamab was able to achieve "substantial" reductions in proteinuria and stabilised kidney function in the 54-subject IGNAZ study that extended for 18 months after the last dose of the antibody.

114

114

pharmaphorum

OCTOBER 28, 2024

MSD and Moderna start a third phase 3 trial of their V940 cancer vaccine, their second in early-stage lung cancer.

118

118

Pharmaceutical Technology

OCTOBER 28, 2024

The enduring effects of redlining on public health, particularly on asthma prevalence, provide a striking example of how discriminatory housing policies from the 20th century continue to shape the well-being of marginalised communities affected by this practice today.

105

105

pharmaphorum

OCTOBER 28, 2024

Apple wins in patent infringement lawsuit with wearable maker Masimo, but fails to get the injunction on sales that it sought

Sales 116

Sales 116

MedCity News

OCTOBER 28, 2024

Clearinghouses are just one great example of how the enhanced exchange of healthcare data can increase efficiency for healthcare providers and the greater healthcare community. The post Increasing Efficiency and Reimbursements with Clearinghouses appeared first on MedCity News.

Healthcare Provider 104

Healthcare Provider Healthcare Healthcare 104

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

OCTOBER 28, 2024

Novartis says Fabhalta shows sustained efficacy in rare disease C3G over 12 months, as it prepares for an FDA filing later this year

FDA 110

FDA 110

MedCity News

OCTOBER 28, 2024

Aliada brings AbbVie an early clinical Alzheimer’s disease drug candidate as well as the platform technology that produced it. Aliada licensed its brain delivery technology from Johnson & Johnson. The post AbbVie Adds Another Alzheimer’s Prospect With $1.4B Aliada Therapeutics Acquisition appeared first on MedCity News.

Prospecting 113

Prospecting Biopharma Pharma 113

pharmaphorum

OCTOBER 28, 2024

Astellas confirmed today it will withdraw its EMA filing for avacincaptad pegol as a treatment for eye disorder geographic atrophy in the EU

104

104

MedCity News

OCTOBER 28, 2024

Novartis is getting global rights to a Monte Rosa Therapeutic molecular glue degrader drug in early clinical testing as a potential treatment for autoimmune disorders. The deal comes months after the pharma giant landed rights to an Arvinas targeted protein degrader for cancer. The post Novartis to Pay $150M for Monte Rosa Glue Drug in the Clinic for Immunology Indications appeared first on MedCity News.

Pharma 122

Pharma Biopharma 122

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Pharmaceutical Technology

OCTOBER 28, 2024

The US FDA has approved Iterum Therapeutics' NDA for ORLYNVAH to treat uncomplicated urinary tract infections (uUTIs).

FDA 98

FDA 98

Pharmaceutical Commerce

OCTOBER 28, 2024

With the design of the new 360,000 square-foot building, the CDMO’s goal is to continue to modernize its Laupheim site.

Media 59

Media Biopharma 59

Pharmaceutical Technology

OCTOBER 28, 2024

China's virtual monopoly on the supply of many APIs could be dangerous for the security of medicine supply to Western countries.

Medicine 95

Medicine Manufacturing 95

PharmaTech

OCTOBER 28, 2024

Emerging therapies, patient-centric medicines, and the ever-changing world of bio/pharmaceuticals complicate technology transfer.

Medicine 59

Medicine Pharmaceutical Patients 59

Advertisement

Pharmaceutical Technology

OCTOBER 28, 2024

The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2024 is a strategic platform for discussion and collaboration among decision makers, researchers and technologists who understand and follow this tendency.

Pharmaceutical 59

Pharmaceutical 59

Pharmaceutical Commerce

OCTOBER 28, 2024

The latest news for pharma industry insiders.

Pharma 59

Pharma 59

Pharmacy Times

OCTOBER 28, 2024

Champions for Vaccine Education, Equity, and Progress reported that the majority of pharmacists believe that it is important to prioritize vaccine development and distribution.

Distribution 58

Distribution Education Patients 58

European Pharmaceutical Review

OCTOBER 28, 2024

Phase III findings showed that TREMFYA ® (guselkumab) is the first IL-23 inhibitor to demonstrate results in subcutaneous induction and maintenance therapy of Crohn’s disease. New Phase III data from Johnson & Johnson has shown that the biologic could become the first IL-23 treatment to offer both a subcutaneous and intravenous induction regimen for the autoimmune condition.

Medicine 59

Medicine Patients Management Leads 59

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmacy Times

OCTOBER 28, 2024

Pharmacists play a key role when it comes to medication substitution, especially for interchangeable biosimilars where allowed by state law.

Medical 52

Medical 52

Pharmaceutical Commerce

OCTOBER 28, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Distribution 52

Distribution Biopharma Marketing 52

Pharmacy Times

OCTOBER 28, 2024

The authors note that exercise beyond 3 times per week was not associated with a lower risk of asthma, and more research is needed to confirm this finding.

52

52

PharmExec

OCTOBER 28, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Advertisement

Distribution

Pharmaceutical Technology

OCTOBER 28, 2024

Ahead of the upcoming DSCSA November deadline, pharma companies reimagine track-and-trace to tackle the US counterfeit drug landscape.

Pharma 52

Pharma 52

PharmExec

OCTOBER 28, 2024

Collaboration seeks to advance the treatment of non-small cell lung cancer by combining Keytruda with Moderna’s novel neoantigen therapy, which has shown positive results across cancer types.

52

52

Pharmaceutical Technology

OCTOBER 28, 2024

UPFs have become a staple of many diets worldwide, but overconsumption is contributing to an obesity epidemic in India.

52

52

Pharmaceutical Commerce

OCTOBER 28, 2024

Albert Thigpen, co-founder, Talentwise Consulting, explains how to use these tactics in order to anticipate the future US healthcare policy environment.

Consulting 52

Consulting Healthcare Healthcare 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales